Globeimmune inc

NA

GBIM


1450 Infinite Drive
Louisville , CO 80027

Executive/
Director

Price

  • Last Close
  • $ 0
    $ +0 0 %
    Dec 6, 2022
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 0
  • Market Cap Full
  • $
  • Shares Outstanding

  • Jan 1, 1970
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -46% 31% 65.7% -17.8% -5% 761.9% -99.7% - - -
Q2 -7.2% 34.2% -3.5% -11.5% 4% -43.7% - - - -
Q3 -35.6% -2% -56.4% -45% 8% -65.7% - - - -
Q4 -76.8% -23.9% -25% -19.4% 40% -11.4% - - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -49%-93%21%-49%-68%262%48%-100%0%0%0%

Earnings

2016 2017 2018 2019 2021 2022 2023
Q1 - - - - - - -
Q2 - - - - - - -
Q3 - - - - - - -
Q4 - - - - - - -
A 0 0 0 0 0 0 0

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - - - -
Equity multiplier - - - - -